Document is current

Any future updates will be listed below

Osimertinib in EGFR-Mutant Non-Small Cell Lung Carcinoma: Clinical Activity and Mechanisms of Resistance

Crossref DOI link: https://doi.org/10.1007/978-3-030-74028-3_4

Published Online: 2021-10-01

Published Print: 2021

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark